Chronic one-kidney hypertension in rabbits. III. Renopressin, a new hypertensive substance

Medullopressin: a new pressor activity from the renal medulla

The kidney contains blood pressure-lowering substances, such as prostaglandin E2 or prostaglandin A2, and blood pressure-raising substances such as thromboxane A2. Most of the postulated substances, however, have not yet been isolated in a pure state and are of unknown structure. In the present study, we separated a chloroform extract from the medulla of pig kidneys using various chromatography procedures. Each fraction was tested in spontaneously hypertensive Wistar rats. One of these fractions caused a powerful blood pressure increase of 30.1 +/- 7.1 mmHg systolic and 34.7 +/- 6 mmHg diastolic (N=7; p=0.0003), reaching its maximum 55 +/- 27 s after completion of the injection and lasting for 201 +/- 59 s. A long-lasting contractile response in porcine and bovine coronary artery rings was observed. In the mouse aortic rings, the contractile response accounted for 0.38 +/- 0.13 g, ie., 31.9 +/- 10.9% of the maximum potassium response (N=11; p=0.003). Because this activity could not be attributed to any known vasoactive substance, it was considered to arise from a novel underlying active substance in the kidney medulla, which we named medullopressin.

Hypertensive factor in different models of experimental hypertension

A hypertensive factor (HF), isolated from rat erythrocytes, has been shown to stimulate in vitro calcium uptake in aortic rings and to elevate blood pressure when injected into normotensive rats. In the present study, we investigated tissue responsiveness to HF in spontaneously hypertensive rats (SHR), Wistar Kyoto rats (WKY), 2-kidney, 1-clip renovascular hypertensive rats and uninephrectomized rats that were given water or saline to drink or that were treated with DOCA and given water or saline to drink (DOCA-salt). Tissue responsiveness was determined by incubating aortic rings from the rats in the different groups with a constant amount of HF and measuring "lanthanum-resistant" calcium uptake. Tissue sensitivity to HF was greater in SHR than in WKY. In contrast, tissue sensitivity to HF was not enhanced in 2-kidney, 1-clip renovascular and DOCA-salt hypertensive rats relative to their appropriate controls. These results suggest that the increased tissue responsiveness to HF found in SHR is not universally associated with elevated blood pressure; increased tissue sensitivity seems to be a specific characteristic of genetic hypertension.

An endogenous peptide that induces long-term blood pressure elevation

A peptide was recently isolated from the blood of spontaneously hypertensive (SH) rats that stimulated an increase of calcium uptake by vascular tissue in vitro. In the present study normotensive rats were given nanomolar amounts of this peptide by intravenous or picomolar amounts by intracerebral injection and the effect on blood pressure was recorded. Injection of the peptide into the circulation had no significant effect on the elevation of blood pressure. By comparison, the injection of the compound into the third ventricle of the brain resulted in the elevation of blood pressure to hypertensive levels. The blood pressure response was characterized by a prolonged period of onset with maximal elevation observed several days after the beginning of treatment. Subsequently, the increase in blood pressure was well maintained with significant elevation noted days following the cessation of treatment.

Spontaneous hypertension: a humoral component

A hypertensive factor (HF) has been partially purified from the erythrocytes of spontaneously hypertensive rats. Injection of the factor produces a sustained elevation of the blood pressure of normotensive rats. The blood pressure response following intravenous injection of the factor is characterized by a prolonged period of onset with maximal elevation obtained several days following the beginning of treatment. Subsequently, the elevation of blood pressure is well maintained and may be observed days or weeks following the cessation of treatment. In addition to its pressor effects, the preparation stimulates an increase in the concentration of "lanthanum-resistant" calcium in aortae excised from normotensive or hypertensive rats. In contrast, the efflux of calcium from aortae in the presence of the factor is enhanced suggesting that the factor involved may induce a change in the lability and exchangeability of calcium stores in aortic tissue. Secondarily, the efflux data indicate that the increase in "lanthanum-resistant" calcium noted in aortae exposed to the erythrocyte extract is due to an increase in calcium uptake by the tissue as opposed to a decrease in the extrusion of the ion.

A hypertensive substance found in the blood of spontaneously hypertensive rats

A substance has been obtained from the blood of spontaneously hypertensive rats which produces a hypertensive elevation of the blood pressure in normotensive rats. The substance is dialyzable and is associated with the erythrocyte membrane. It appears to be relatively long-lived in its effect on arterial pressure. The erythrocyte fractions that exhibit pressor activity also stimulate the in vitro uptake of calcium by aortas obtained from normotensive animals. This suggests that the hypertensive factor or related substances may influence the calcium metabolism of vascular tissue.

Surgical reversal of two-kidney one clip hypertension during inhibition of the renin-angiotensin system

Conscious rats with two-kidney one clip Goldblatt hypertension had the constricting clip removed during continuous infusion of either dextrose, saralasin, or captopril. Other dextrose-infused animals underwent removal of the ischemic kidney or a sham procedure. Direct arterial blood pressure (BP) was recorded throughout the 15-hour preoperative and subsequent 24-hour postoperative period. Rats were studied in the "early" phase (1-3 weeks duration) or "chronic" phase (greater than 4 months) of hypertension. Animals subjected to a sham procedure returned to preoperative BP values. The BP of animals unclipped or nephrectomized did not return to previous hypertensive levels. Instead, a biphasic response was seen where BP partially recovered from an operative fall and then slowly declined to normal at 24 hours; this effect occurred in both stages of hypertension. At 24 hours, removal of the ischemic kidney was as effective as removal of the constricting clip in the correction of both early and chronic phase hypertension. Rats infused with saralasin or captopril demonstrated an acute (within 2 hours) and sustained fall in BP, but not to normotensive levels. This fall was significant in all animals (p less than 0.01) apart from chronic phase rats infused with saralasin where no significant fall was seen. Although animals infused with saralasin or captopril commenced at a lower preoperative BP, the biphasic pattern of response to unclipping was identical to that of dextrose-infused unclipped rats. Thus, sustained inhibition of the renin-angiotensin system did not modify the correction of hypertension produced by removal of the constricting clip, and the response to surgical correction did not appear to be entirely mediated by changes in the activity of the renin-angiotensin system, particularly in the chronic stage. Equally, the rapidity of correction is not consistent with a role of vascular hypertrophy.

Renin as a risk factor for atherogenesis. Effects of hypercholesterolemia and two-kidney--one-clip hypertension in the rabbit

Four groups of New Zealand rabbits were used to study the effect of plasma renin activity (PRA) on atherogenesis. Control groups were fed normal rabbit chow (Group I) or chow supplemented with 0.25% cholesterol and 0.75% corn oil (Group II). The two-kidney--one-clip (2K-1C) hypertensive model was produced in 2 additional groups; Group III (normal diet) and Group IV (atherogenic diet). The latter 2 groups were subgrouped according to PRA levels. Each group was examined over a 7-month period. Group II became hyperlipidemic and developed extensive lipoidal vascular lesions. Mean arterial pressure remained normal throughout the experimental period; PRA fell below normal. Group III and Group IV rabbits developed sustained hypertension irrespective of circulating PRA. The atheromas of Group III were predominantly microscopic and fibromuscular; the extent of aortic and coronary artery involvement was independent of renin response. The most extensive and complicated atheromas were seen in the 2K-1C rabbits consuming the atherogenic diet (Group IV). The lesions were mostly lipoidal, although some were fibromuscular. These results demonstrated that cardiovascular lesions and atherogenesis were exacerbated in the 2K-1C rabbits on a high cholesterol diet; however, PRA was excluded as the cause.

The role of renin in the control of the circulation and in hypertensive disease

Renin is a hormone secreted by the juxtaglomerular cells of the kidney; it interacts with a plasma protein substrate to produce a decapeptide prohormone angiotensin I. Converting hormone located on vascular endothelium converts the decapeptide to an octapeptide, angiotensin II, which effects vasoconstriction, the secretion of aldosterone by the adrenal cortex, and retention of sodium by the kidney. The biosynthesis and control of renin secretion are not well understood, and the question as to whether renin is synthesized and stored in a larger precursor form is as yet unresolved. Whether or not higher molecular weight or inactive forms of renin in plasma have a role in controlling renin activity or whether they simply represent a degradative pathway for renin is as yet uncertain. The availability of several inhibitors of the renin-angiotensin system has served to define the role of renin both in normal cardiovascular homeostasis and in renovascular hypertension. It appears that renin plays an important role in maintaining blood pressure in the salt- or volume-depleted state and that it is responsible for the initial phases of renovascular hypertension in any model of this disease process. Renin's part in chronic renovascular hypertension depends on whether or not sodium is permitted to accumulate. If sodium intake is restricted or if sodium excretion is unimpaired (such as in two-kidney renovascular hypertension models), renin continues to play a significant role during the chronic phase.

Extracellular fluid distribution in rats with chronic one- and two-kidney Goldblatt hypertension

1. The influence of the intact kidney on blood pressure, extracellular fluid volume (ECF, ferrocyanide space) and ECF volume distribution was studied in rats 60 days after constriction of the contralateral renal artery. 2. Renal artery constriction increased both blood pressure and ECF levels. The rise of both variables was more pronounced in rats with the contralateral kidney removed (one-kidney rats) than with the contralateral kidney intact (two-kidney rats). 3. The interstitial fluid volume increased similarly in both experimental groups, the more pronounced ECF increase in the more severly hypertensive one-kidney rats being due to increased plasma volume. In the less hypertensive two-kidney group the plasma volume was not increased significantly but correlated positively with the blood pressure levels. 4. The plasma volume/interstitial fluid volume ratio was decreased in the two-kidney group but did not differ from control values in the one-kidney group thus resembling the ECF partition reported in the hypo-and hypervolaemic type of essential hypertension, respectively. 5. It is suggested that the antihypertensive influence of the intact kidney may be partly due to its ability to escape from the sodium-retaining mechanism activated by renal artery stenosis, which determines the degree of plasma volume expansion and, in connection with this, also the degree of blood pressure elevation.

The sodium-potassium pump in volume expanded hypertension

Decreased arterial Na+-K+ pump and cardiac Na+, K-+ATPase activities have now been demonstrated in several types of experimental volume expanded hypertension. The changes are not secondary to elevated pressure since they also occur in veins and right ventricle where the pressure is not elevated. Decreased arterial Na+-K+ pump activity can be reproduced by acute volume expansion of the normal rat and plasma extracts from this rat suppress pump activity when applied to arteries from another rat. Suppression of Na+-K+ pump activity in arteries, veins and heart, with ouabain for example, leads to increased contractile activity. Thus the volume expansion, reduced pump activity, and hypertension appear to be causally related through an ouabain-like humoral agent. Certain other evidence suggests that the pump defect extends to the sympathetic nerve endings, thereby reducing the efficiency of neural compensatory mechanisms.